[go: up one dir, main page]

YU2901A - Jedinjenja, kompozicije i postupci za stimulisanje neuronskog rasta i elongacija - Google Patents

Jedinjenja, kompozicije i postupci za stimulisanje neuronskog rasta i elongacija

Info

Publication number
YU2901A
YU2901A YU2901A YU2901A YU2901A YU 2901 A YU2901 A YU 2901A YU 2901 A YU2901 A YU 2901A YU 2901 A YU2901 A YU 2901A YU 2901 A YU2901 A YU 2901A
Authority
YU
Yugoslavia
Prior art keywords
compounds
compositions
elongation
methods
neuronal growth
Prior art date
Application number
YU2901A
Other languages
English (en)
Inventor
Susumu Katoh
Hiroshi Kawakami
Hiroki Tada
Maria Angelica Linton
Original Assignee
Agouron Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals Inc. filed Critical Agouron Pharmaceuticals Inc.
Publication of YU2901A publication Critical patent/YU2901A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Ovaj pronalazak se odnosi na jedinjenja koja inhibiraju peptidil-prolil izomere (rotomaze) enzimsku aktivnost FK-506 vezujući protein (FKBP) i kompozicije koje sadrže ova jedinjenja kako je dato u opisu. Farmaceutske kompozicije koje sadrže takva jedinjenja pomažu pri stimulaciji rasta neuita u nervnim ćelijama i dovode do regeneracije nerva. Metodi tretmana nervnih ćelija takvim kompozicijama koriste da podpomognu obnavljanje oštećenja na neuronima izazvanih bolestima ili fizičkom traumom.
YU2901A 1998-07-17 1999-07-15 Jedinjenja, kompozicije i postupci za stimulisanje neuronskog rasta i elongacija YU2901A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9329998P 1998-07-17 1998-07-17
US13288499P 1999-05-06 1999-05-06

Publications (1)

Publication Number Publication Date
YU2901A true YU2901A (sh) 2004-05-12

Family

ID=26787372

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2901A YU2901A (sh) 1998-07-17 1999-07-15 Jedinjenja, kompozicije i postupci za stimulisanje neuronskog rasta i elongacija

Country Status (35)

Country Link
US (1) US6630472B1 (sh)
EP (1) EP1098897B1 (sh)
JP (1) JP2002520413A (sh)
KR (1) KR20010071920A (sh)
CN (1) CN1318067A (sh)
AP (1) AP2001002052A0 (sh)
AT (1) ATE268772T1 (sh)
AU (1) AU756912B2 (sh)
BG (1) BG105268A (sh)
BR (1) BR9912423A (sh)
CA (1) CA2337377A1 (sh)
DE (1) DE69917907T2 (sh)
DK (1) DK1098897T3 (sh)
EA (1) EA200100149A1 (sh)
EE (1) EE200100032A (sh)
ES (1) ES2226409T3 (sh)
GE (1) GEP20043368B (sh)
HR (1) HRP20010118A2 (sh)
HU (1) HUP0200637A3 (sh)
ID (1) ID27428A (sh)
IL (1) IL140676A0 (sh)
IS (1) IS5805A (sh)
LT (1) LT4850B (sh)
LV (1) LV12665B (sh)
NO (1) NO20010191L (sh)
NZ (1) NZ509211A (sh)
OA (1) OA11581A (sh)
PL (1) PL345598A1 (sh)
PT (1) PT1098897E (sh)
SI (1) SI20638A (sh)
SK (1) SK462001A3 (sh)
TR (1) TR200100122T2 (sh)
WO (1) WO2000004020A1 (sh)
YU (1) YU2901A (sh)
ZA (1) ZA200100320B (sh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818643B1 (en) * 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
MXPA03010255A (es) * 2001-05-10 2005-03-07 Agouron Pharma Ligandos heterobiciclicos de proteinas de union a fk-506.
WO2015110271A1 (en) * 2014-01-24 2015-07-30 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders
EP2899192A1 (en) * 2014-01-24 2015-07-29 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5196352A (en) 1989-01-19 1993-03-23 Merck & Co., Inc. New FK-506 cytosolic binding protein
US5109112A (en) 1989-01-19 1992-04-28 Merck & Co., Inc. FK-506 cytosolic binding protein
US5192773A (en) 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
US5256656A (en) * 1990-07-31 1993-10-26 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives
US5187166A (en) * 1990-07-31 1993-02-16 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives and their use as antiemetics
CA2068062A1 (en) 1991-05-07 1992-11-08 Stephen A. Parent Yeast mutants
US5362629A (en) 1991-08-05 1994-11-08 President And Fellows Of Harvard College Detection of immunosuppressants
US5344831A (en) * 1992-01-31 1994-09-06 Nisshin Flour Milling Co., Ltd. Diazabicyclo derivatives
DE4219973A1 (de) 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
US5318895A (en) 1992-10-05 1994-06-07 Merck & Co., Inc. Aspergillus niger mutants
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
JP3235913B2 (ja) * 1993-07-30 2001-12-04 エーザイ株式会社 アミノ安息香酸誘導体
US5612350A (en) 1993-11-30 1997-03-18 Abbott Laboratories Macrocyclic immunomodulators with novel cyclohexyl ring replacements
DE4341402A1 (de) 1993-12-04 1995-06-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
US5457182A (en) 1994-02-15 1995-10-10 Merck & Co., Inc. FK-506 cytosolic binding protein, FKBP12.6
US5622866A (en) 1994-06-23 1997-04-22 Merck & Co., Inc. Expression cassettes useful in construction of integrative and replicative expression vectors for Streptomyces
US5696135A (en) 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5614547A (en) 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US6037370A (en) 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5786378A (en) 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5780484A (en) 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US5840736A (en) 1996-11-13 1998-11-24 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5811434A (en) 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
PA8442401A1 (es) 1996-12-09 2000-05-24 Guilford Pharm Inc Inhibidores polipropilos de ciclofilina
US5874449A (en) 1996-12-31 1999-02-23 Gpi Nil Holdings, Inc. N-linked sulfonamides of heterocyclic thioesters
US5935989A (en) 1996-12-31 1999-08-10 Gpi Nil Holdings Inc. N-linked ureas and carbamates of heterocyclic thioesters
US5721256A (en) 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
ZA98825B (en) 1997-02-27 1998-10-19 Guilford Pharm Inc Method of using neurotrophic carbamates and ureas
US5846979A (en) 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones

Also Published As

Publication number Publication date
SI20638A (sl) 2002-02-28
OA11581A (en) 2004-07-23
DE69917907D1 (de) 2004-07-15
HUP0200637A3 (en) 2003-05-28
EP1098897A1 (en) 2001-05-16
ES2226409T3 (es) 2005-03-16
DK1098897T3 (da) 2004-10-18
LV12665B (lv) 2001-11-20
NZ509211A (en) 2002-10-25
WO2000004020A1 (en) 2000-01-27
HRP20010118A2 (en) 2002-02-28
KR20010071920A (ko) 2001-07-31
LT4850B (lt) 2001-10-25
CN1318067A (zh) 2001-10-17
BG105268A (en) 2001-11-30
AP2001002052A0 (en) 2001-03-31
GEP20043368B (en) 2004-04-13
ID27428A (id) 2001-04-05
PT1098897E (pt) 2004-10-29
LT2001012A (en) 2001-07-25
ATE268772T1 (de) 2004-06-15
EA200100149A1 (ru) 2001-08-27
DE69917907T2 (de) 2005-06-30
EP1098897B1 (en) 2004-06-09
US6630472B1 (en) 2003-10-07
JP2002520413A (ja) 2002-07-09
AU756912B2 (en) 2003-01-23
ZA200100320B (en) 2002-07-11
PL345598A1 (en) 2001-12-17
LV12665A (en) 2001-05-20
AU4996399A (en) 2000-02-07
BR9912423A (pt) 2001-06-05
EE200100032A (et) 2002-06-17
IL140676A0 (en) 2002-02-10
IS5805A (is) 2001-01-12
TR200100122T2 (tr) 2001-08-21
CA2337377A1 (en) 2000-01-27
NO20010191D0 (no) 2001-01-12
SK462001A3 (en) 2002-02-05
NO20010191L (no) 2001-03-16
HUP0200637A2 (en) 2002-08-28

Similar Documents

Publication Publication Date Title
UY26464A1 (es) " compuestos, composiciones y métodos para estimular el crecimiento y elongación de neuronas"
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
NZ310339A (en) Compositions for stimulating neurite growth comprising a neurotrophic amount of a compound with affinity for FKBP12 and a neurotrophic agent
BG102072A (bg) Инхибитори на ротамазна ензимна активност
EP1378247A4 (en) ACTIVE SUBSTANCES FOR TREATMENT OF SEARCH TROUBLESHOOTING
BR0315645A (pt) Polipetìdeos de fusão de actrib e seus usos
EA199800393A1 (ru) Композиции и способы их применение для лечения поражения костей
EA199900464A1 (ru) Способы и композиции для стимуляции роста невритов
EA199900462A1 (ru) Способы и композиции для стимуляции роста невритов, использующие соединения с афинностью к fkbp12 в комбинации с нейротрофическими факторами
TW200510306A (en) Novel hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them
DE60026568D1 (de) Hydantoin derivate, pharmazeutische zusammensetzungen und verfahren zu ihrer verwendung
WO2008006544A3 (de) Verwendung von gelatine und einem vernetzungsmittel zur herstellung einer vernetzenden therapeutischen zusammensetzung
DE60019318D1 (de) Zusammensetzungen und verfahren zur inhibierung vom zellulären g2-übergang und sensitisierung von zellen gegen dna-schädigenden wirkstoffe
BR9906926A (pt) Composições e métodos para tratamento de células tendo dna de minuto duplo
EP0859636A4 (en) HYALURONIC ACID USED AS A DNA CARRIER FOR GENE THERAPY AND ANTI-SENSE DNA OF THE VASCULAR ENDOTHELIUM GROWTH FACTOR FOR THE TREATMENT OF ABNORMAL RETINA VASCULARIZATION
EA200100342A1 (ru) Связывающие соединения адгезионной молекулы нервной клетки
EA200500934A1 (ru) Соединения, модулирующие активность киназного белка множественных линий, и способы лечения нейродегенеративных и воспалительных заболеваний
YU2901A (sh) Jedinjenja, kompozicije i postupci za stimulisanje neuronskog rasta i elongacija
WO2001042784A3 (en) Methods for screening compounds active on neurons
BRPI0409683A (pt) 5-hidroxiindóis com grupos n-óxido e seu emprego como agentes terapêuticos
WO1997014966B1 (en) Method of activating a novel ligand regulatory pathway
He et al. L-NMMA and 1400W, inhibitors of iNOS, attenuate the induction of iNOS and NO in primary rabbit costal chondrocytes by fluoride
NO20060095L (no) Celler anvendt som baerere for bakterier
Neal Release of a myogenic trophic factor from the neuromuscular junction during induced transmitter discharge
WO2000061180A3 (en) Products and methods for treating ptp lar related diseases